Miss Nathalie Nataren

Miss Nathalie Nataren

Higher Degree by Research Candidate

School of Pharmacy and Biomedical Science

College of Health

Year Citation
2025 Thompson, E. J., Dorward, E. L., Jurrius, K., Nataren, N., Tondl, M., Myo Min, K. K., . . . Bonder, C. S. (2025). Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry. Molecular Oncology, online(9), 1-20.
DOI Scopus2 WoS2 Europe PMC1
2025 Mokhtar, S. M. A., Nataren, N. J., Evans, D. R., Moore, M., Bradley, S., MacHacaz Palmar, S., . . . Yamada, M. (2025). Molecular and histological evidence for the biocompatibility of PEDOT-coated microneedles in human skin.. Journal Of Materials Chemistry B, 13(22), 6393-6401.
DOI Scopus2 WoS1
2023 Nataren, N., Yamada, M., & Prow, T. (2023). Molecular Skin Cancer Diagnosis: Promise and Limitations. Journal of Molecular Diagnostics, 25(1), 17-35.
DOI
2018 Branford, S., Wang, P., Yeung, D. T., Thomson, D., Purins, A., Wadham, C., . . . Hughes, T. P. (2018). Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease. Blood, 132(9), 948-961.
DOI Scopus169 WoS158 Europe PMC140
2016 Barnett, C., Nataren, N., Klingler-Hoffmann, M., Schwarz, Q., Chong, C., Lee, Y., . . . Scott, H. (2016). Ectrodactyly and lethal pulmonary acinar dysplasia associated with homozygous FGFR2 mutations identified by exome sequencing. Human Mutation, 37(9), 955-963.
DOI Scopus31 WoS23 Europe PMC23
2016 Barnett, C. P., Nataren, N. J., Klingler-Hoffmann, M., Schwarz, Q., Chong, C. E., Lee, Y. K., . . . Scott, H. S. (2016). Cover Image, Volume 37, Issue 9. Human Mutation, 37(9), i.
DOI
2015 Gagliardi, L., Nataren, N., Feng, J., Schreiber, A., Hahn, C., Conwell, L., . . . Scott, H. (2015). Allan-Herndon-Dudley syndrome with unusual profound sensorineural hearing loss. American Journal of Medical Genetics, Part A, 167(8), 1872-1876.
DOI Scopus10 WoS10 Europe PMC9

Connect With Me

External Profiles

Other Links